How does MOTS-c work?
MOTS-c activates the cellular energy sensor AMPK (AMP-activated protein kinase), which then drives downstream effects on glucose uptake, fatty-acid oxidation, and mitochondrial biogenesis. The compound is a short bioactive peptide whose coding sequence sits inside the mitochondrial 12S rRNA gene — unusual provenance among research peptides.
What the research literature says
MOTS-c is one of the small set of mitochondrial-derived peptides (MDPs) encoded in the mitochondrial genome rather than the nuclear genome. The Lee characterisation paper established the compound’s role as a metabolic regulator promoting systemic insulin sensitivity and glucose homeostasis in mouse models, with AMPK activation as the primary downstream signalling node (PMID 25738459). The follow-up Lee work extended the framework into muscle and adipose-tissue metabolism specifically (PMID 27216708).
The Kim nuclear-translocation work characterised the metabolic-stress-responsive behaviour where MOTS-c translocates from the cytosol to the nucleus under metabolic-stress conditions, regulating nuclear gene expression in response (PMID 29983246). The Yang exercise-synergy work documented synergistic interaction between MOTS-c and exercise intervention in regulating PGC-1α expression and insulin resistance via AMPK signalling (PMID 33722744).
Active AMPK phosphorylates dozens of downstream substrates with the integrated effect of switching cellular metabolism from anabolic (energy-consuming) to catabolic (energy-generating) modes. Key outputs include activation of glucose uptake via GLUT4 trafficking, stimulation of fatty-acid oxidation via inhibition of acetyl-CoA carboxylase, promotion of mitochondrial biogenesis via PGC-1α activation, and suppression of mTORC1-driven protein synthesis.
Why this matters in research context
MOTS-c is positioned in the published research as a candidate signalling molecule mediating systemic metabolic responses to exercise and caloric-restriction interventions. Researchers studying AMPK-axis pharmacology with MOTS-c should distinguish between the direct mitochondrial-derived-peptide signalling (the compound’s intrinsic mechanism) and the downstream AMPK-axis effects (which overlap with the broader AMPK-activator literature including metformin and direct AMPK-targeting small molecules).
Related compounds
- MOTS-c 10mg — the compound covered by this answer
- 5-Amino-1MQ 10mg — NNMT inhibitor affecting the NAD+/sirtuin axis that interacts with AMPK
Related research questions
References
- Lee C et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab 2015;21(3):443-454. [PMID 25738459]
- Lee C et al. MOTS-c: A novel mitochondrial-derived peptide regulating muscle and fat metabolism. Free Radic Biol Med 2016;100:182-187. [PMID 27216708]
- Kim KH et al. The Mitochondrial-Encoded Peptide MOTS-c Translocates to the Nucleus to Regulate Nuclear Gene Expression in Response to Metabolic Stress. Cell Metab 2018;28(3):516-524. [PMID 29983246]
- Yang B et al. MOTS-c interacts synergistically with exercise intervention to regulate PGC-1α expression, attenuate insulin resistance and enhance glucose metabolism in mice via AMPK signaling pathway. Biochim Biophys Acta Mol Basis Dis 2021;1867(6):166126. [PMID 33722744]
Research-questions pages describe research-context use of peptide-research terminology. They do not constitute medical, veterinary, or clinical advice. MOTS-c is sold strictly as a research-grade reagent for laboratory and bench research applications.